BBWI

Bath & Body Works, Inc. [BBWI] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

BBWI Stock Summary

Top BBWI Correlated Resources

BBWI


Top 10 Correlated ETFs

BBWI


Top 10 Correlated Stocks

BBWI


In the News

05:46 16 Apr 2024 BBWI

Bath & Body Works: Tapping Into The Rapidly Growing Male Grooming Market

BBWI has a strong loyalty program customer base that accounts for ~80% of sales and is still growing, proving effective in driving customer acquisition and retention. Its growing men's line has proven that BBWI has effectively diversified its market into the men's category and reduced its reliance on a single demographic. My relative valuation brings me to a target price of ~$51.21, which represents an upside potential of 16%.

11:00 16 Apr 2024 BBWI

Bath & Body Works to Present at the Bank of America Consumer & Retail Conference

COLUMBUS, Ohio, March 05, 2024 (GLOBE NEWSWIRE) -- Bath & Body Works, Inc. (NYSE: BBWI) announced today that Eva Boratto, chief financial officer, will participate in a fireside chat at the Bank of America Consumer & Retail Conference on Tuesday, March 12, 2024, at 8:00 a.m. EDT.

01:25 16 Apr 2024 BBWI

Bath & Body Works, Inc. (BBWI) Q4 2023 Earnings Call Transcript

Bath & Body Works, Inc. (BBWI) Q4 2023 Earnings Call Transcript

10:36 16 Apr 2024 BBWI

Compared to Estimates, Bath & Body Works (BBWI) Q4 Earnings: A Look at Key Metrics

While the top- and bottom-line numbers for Bath & Body Works (BBWI) give a sense of how the business performed in the quarter ended January 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

12:30 16 Apr 2024 BBWI

Will Q4 Results Help Extend The 13% Gain In Bath & Body Works Stock Since Early 2023?

Bath & Body Works stock (NYSE: BBWI), the largest specialty home fragrance & body care product retailer in the U.S., formerly known as L Brands, is scheduled to report its fiscal fourth-quarter results on Thursday, February 29. We expect BBWI stock to likely trade lower with revenues and earnings missing expectations in its fourth-quarter results.

08:30 16 Apr 2024 BBWI

Bath & Body Works to Report Fourth Quarter and Fiscal 2023 Financial Results on February 29, 2024

COLUMBUS, Ohio, Feb. 15, 2024 (GLOBE NEWSWIRE) -- Bath & Body Works, Inc. (NYSE: BBWI) announced today that it will report its fourth quarter and fiscal 2023 financial results before market open on Thursday, February 29, 2024. In conjunction with this release, the company will host a conference call that morning at 9:00 a.m. EST, during which Gina Boswell, chief executive officer, Eva Boratto, chief financial officer, and Julie Rosen, president, retail, will provide a business update and discuss the company's results and 2024 outlook. Supplemental materials will be posted approximately 45 minutes prior to the start of the conference call on the events and presentations page in the investors section of the company's website at bbwinc.com.

07:47 16 Apr 2024 BBWI

Short sellers boosted by ‘Hedge Fund Nirvana' that sees most heavily-shorted companies suffer

Hedge funds with long/short strategies have benefited in 2024 from a macroeconomic environment that has hit the most heavily shorted stocks particularly hard compared to their less shorted rivals, a new UBS report says.

12:29 16 Apr 2024 BBWI

Bath & Body Works: Great Execution And Performance

BBWI reported better-than-expected sales and gross margin expansion in Q3 2024. The company's revenue growth is tracking well against management's guidance. As the macro situation improves in 2024, it bodes well for BBWI growth.

08:30 16 Apr 2024 BBWI

Bath & Body Works to Present at the Morgan Stanley Global Consumer & Retail Conference

COLUMBUS, Ohio, Nov. 29, 2023 (GLOBE NEWSWIRE) -- Bath & Body Works, Inc. (NYSE: BBWI) announced today that Gina Boswell, chief executive officer, and Eva Boratto, chief financial officer, will participate in a fireside chat at the Morgan Stanley Global Consumer & Retail Conference on Wed., Dec. 6, 2023, at 8:45 a.m. EST.

09:40 16 Apr 2024 BBWI

Investors could clean up with Bath & Body Works stock at $30

From scented candles to air fresheners to hand soaps, Bath & Body Works, Inc. NYSE: BBWI has many holiday shopping deals that are worth a sniff — not to mention its stock.

BBWI Financial details

Company Rating
Sell
Market Cap
10.17B
Income
878M
Revenue
7.43B
Book val./share
-7.23
Cash/share
4.82
Dividend
0.8
Dividend %
1.78%
Employees
8.98K
Optionable
No
Shortable
Yes
Earnings
16 May 2024
P/E
13.96
Forward P/E
13.76
PEG
11.47
P/S
1.37
P/B
-4.82
P/C
9.25
P/FCF
13.05
Quick Ratio
0.43
Current Ratio
1.39
Debt / Equity
-2.81
LT Debt / Equity
-2.7
-
-
EPS (TTM)
3.87
EPS next Y
3.24
EPS next Q
0.53
EPS this Y
11.59%
EPS next Y
-16.21%
EPS next 5Y
26.06%
EPS last 5Y
NAN%
Revenue last 5Y
6.57%
Revenue Q/Q
86.43%
EPS Q/Q
394.23%
-
-
-
-
SMA20
-
SMA50
6.98%
SMA100
53.33%
Inst Own
68%
Inst Trans
0.73%
ROA
14%
ROE
-34%
ROC
0.32%
Gross Margin
43%
Oper. Margin
17%
Profit Margin
10%
Payout
25%
Shs Outstand
224.9M
Shs Float
222.29M
-
-
-
-
Target Price
47.31
52W Range
27.3-50.34
52W High
-10.82%
52W Low
+65.15%
RSI
44
Rel Volume
0.5
Avg Volume
2.69M
Volume
1.34M
Perf Week
-1.98%
Perf Month
-2.32%
Perf Quarter
50.85%
Perf Half Y
47.65%
-
-
-
-
Beta
1.876
-
-
Volatility
0.69%, 1.61%
Prev Close
-1.39%
Price
44.59
Change
-2.47%

BBWI Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2024-02-03

Metric History 2020-02-012021-01-302022-01-292023-01-28 2024-02-03
2.02K2.02K2.02K2.02K2.02K
Revenue per share
19.5823.1429.332.5932.58
Net income per share
-1.333.044.963.453.85
Operating cash flow per share
4.487.335.554.934.18
Free cash flow per share
2.826.514.543.522.88
Cash per share
5.4314.047.365.314.75
Book value per share
-5.43-2.38-5.64-9.5-7.14
Tangible book value per share
-9.18-6.12-8.59-12.92-10.61
Share holders equity per share
-5.43-2.38-5.64-9.5-7.14
Interest debt per share
34.2335.5623.827.5921.55
Market cap
5.17B9.16B14.7B10.36B9.91B
Enterprise value
12.75B14.71B18.73B15.18B14.4B
P/E ratio
-14.1210.8511.0312.9511.28
Price to sales ratio
0.961.421.871.371.33
POCF ratio
4.184.499.859.0510.38
PFCF ratio
6.645.0612.0312.6915.1
P/B Ratio
-3.45-13.84-9.68-4.7-6.09
PTB ratio
-3.45-13.84-9.68-4.7-6.09
EV to sales
2.362.292.382.011.94
Enterprise value over EBITDA
8.147.098.629.419.28
EV to operating cash flow
10.317.2212.5613.2715.09
EV to free cash flow
16.388.1215.3318.621.94
Earnings yield
-0.070.090.090.080.09
Free cash flow yield
0.150.20.080.080.07
Debt to equity
-6.06-14.28-3.96-2.75-2.81
Debt to assets
0.90.8211.10.84
Net debt to EBITDA
4.842.681.862.992.89
Current ratio
1.371.972.331.641.64
Interest coverage
2.813.715.183.953.72
Income quality
-3.382.421.121.431.09
Dividend Yield
0.060.010.010.020.02
Payout ratio
-0.910.10.090.230.21
Sales general and administrative to revenue
0.250.230.230.250.26
Research and developement to revenue
00000
Intangibles to total assets
0.10.090.130.140.15
Capex to operating cash flow
-0.37-0.11-0.18-0.29-0.31
Capex to revenue
-0.08-0.04-0.03-0.04-0.04
Capex to depreciation
-0.78-0.44-0.74-1.48-1.11
Stock based compensation to revenue
0.020.010.010.010.01
Graham number
12.7312.7525.0827.1624.87
ROIC
0.070.10.270.210.28
Return on tangible assets
-0.040.080.250.170.19
Graham Net
-33.51-26.95-18.7-25.62-24.04
Working capital
873M2.75B1.72B887M826M
Tangible asset value
-2.53B-1.7B-2.31B-3B-2.42B
Net current asset value
-8.38B-6.65B-4.53B-5.43B-4.97B
Invested capital
-6.06-14.28-3.96-2.75-2.81
Average receivables
336.5M287.5M254.5M233M225M
Average payables
679M665M559M445M417.5M
Average inventory
1.27B1.28B991M709M709.5M
Days sales outstanding
20.6615.2611.1110.9111.01
Days payables outstanding
78.2574.6839.4338.5833.06
Days of inventory on hand
155.65139.264.2660.1161.78
Receivables turnover
17.6623.9232.8433.4533.17
Payables turnover
4.664.899.269.4611.04
Inventory turnover
2.342.625.686.075.91
ROE
0.24-1.27-0.88-0.36-0.54
Capex per share
-1.66-0.82-1-1.41-1.31

Quarterly Fundamentals Overview

Last date of statement is 2024-02-03 for Q4

Metric History 2023-01-282023-04-292023-07-292023-10-28 2024-02-03
2.02K2.02K2.02K2.02K2.02K
Revenue per share
12.646.16.846.8812.94
Net income per share
1.90.350.430.522.57
Operating cash flow per share
4.710.190.14-0.224.12
Free cash flow per share
4.38-0.21-0.23-0.533.9
Cash per share
5.394.573.461.814.82
Book value per share
-9.65-9.48-9.45-9.36-7.23
Tangible book value per share
-13.12-12.94-12.93-12.85-10.75
Share holders equity per share
-9.65-9.48-9.45-9.36-7.23
Interest debt per share
26.8826.4926.2125.5220.69
Market cap
10.2B8.04B8.33B6.42B9.78B
Enterprise value
15.02B12.97B13.43B11.72B14.27B
P/E ratio
5.8724.8121.0413.494.22
Price to sales ratio
3.535.765.344.113.36
POCF ratio
9.47182.68252.46-131.0610.56
PFCF ratio
10.19-164.04-160.21-53.0711.13
P/B Ratio
-4.63-3.7-3.87-3.02-6.01
PTB ratio
-4.63-3.7-3.87-3.02-6.01
EV to sales
5.29.298.627.54.9
Enterprise value over EBITDA
20.8349.1348.1437.4418.65
EV to operating cash flow
13.95294.77407.03-239.1615.41
EV to free cash flow
15-264.69-258.31-96.8516.25
Earnings yield
0.040.010.010.020.06
Free cash flow yield
0.1-0.01-0.01-0.020.09
Debt to equity
-2.75-2.75-2.73-2.69-2.81
Debt to assets
1.11.111.131.090.84
Net debt to EBITDA
6.6918.6818.2816.925.87
Current ratio
1.641.631.561.391.64
Interest coverage
7.582.032.192.638.08
Income quality
2.480.540.33-0.411.6
Dividend Yield
00.010.010.010
Payout ratio
0.110.570.460.380.08
Sales general and administrative to revenue
0.210.30.280.30
Research and developement to revenue
00000
Intangibles to total assets
0.140.150.150.150.15
Capex to operating cash flow
-0.07-2.11-2.581.47-0.05
Capex to revenue
-0.03-0.07-0.05-0.05-0.02
Capex to depreciation
-1.29-1.48-1.29-1.03-0.69
Stock based compensation to revenue
00.010.010.010
Graham number
20.318.689.6110.5120.46
ROIC
0.10.030.030.030.16
Return on tangible assets
0.090.020.020.030.12
Graham Net
-26.02-26.17-26.47-27.33-24.36
Working capital
887M803M680M550M826M
Tangible asset value
-3B-2.96B-2.95B-2.92B-2.42B
Net current asset value
-5.43B-5.45B-5.46B-5.41B-4.97B
Invested capital
-2.75-2.75-2.73-2.69-2.81
Average receivables
234M185.5M149M175M210.5M
Average payables
543.5M440.5M467M567.5M503.5M
Average inventory
989M740M794.5M1.01B957.5M
Days sales outstanding
7.049.358.8311.356.92
Days payables outstanding
24.9847.9348.7964.1321.7
Days of inventory on hand
38.9386.7478.57123.2440.55
Receivables turnover
12.789.6310.197.9313
Payables turnover
3.61.881.841.44.15
Inventory turnover
2.311.041.150.732.22
ROE
-0.2-0.04-0.05-0.06-0.36
Capex per share
-0.33-0.41-0.37-0.32-0.21

BBWI Frequently Asked Questions

What is Bath & Body Works, Inc. stock symbol ?

Bath & Body Works, Inc. is a US stock , located in Columbus of Oh and trading under the symbol BBWI

Is Bath & Body Works, Inc. buy or a sell ?